» Articles » PMID: 17035276

Clinical Features of Dysthyroid Optic Neuropathy: a European Group on Graves' Orbitopathy (EUGOGO) Survey

Abstract

Background: This study was performed to determine clinical features of dysthyroid optic neuropathy (DON) across Europe.

Methods: Forty seven patients with DON presented to seven European centres during one year. Local protocols for thyroid status, ophthalmic examination and further investigation were used. Each eye was classified as having definite, equivocal, or no DON.

Results: Graves' hyperthyroidism occurred in the majority; 20% had received radioiodine. Of 94 eyes, 55 had definite and 17 equivocal DON. Median Clinical Activity Score was 4/7 but 25% scored 3 or less, indicating severe inflammation was not essential. Best corrected visual acuity was 6/9 (Snellen) or worse in 75% of DON eyes. Colour vision was reduced in 33 eyes, of which all but one had DON. Half of the DON eyes had normal optic disc appearance. In DON eyes proptosis was > 21 mm (significant) in 66% and visual fields abnormal in 71%. Orbital imaging showed apical muscle crowding in 88% of DON patients. Optic nerve stretch and fat prolapse were infrequently reported.

Conclusion: Patients with DON may not have severe proptosis and orbital inflammation. Optic disc swelling, impaired colour vision and radiological evidence of apical optic nerve compression are the most useful clinical features in this series.

Citing Articles

Comprehensive Visualization of Choroidal Alterations in Thyroid Eye Disease With Ultra-Widefield OCT Angiography.

Wang Y, Rao T, Zhou J, You D, Yang J, Suo L Invest Ophthalmol Vis Sci. 2025; 66(2):25.

PMID: 39928314 PMC: 11812615. DOI: 10.1167/iovs.66.2.25.


Altered static and dynamic spontaneous brain activity in patients with dysthyroid optic neuropathy: a resting-state fMRI study.

Lu J, Hu H, Zhou J, Jiang W, Pu X, Chen H Front Neurosci. 2025; 18():1530967.

PMID: 39867455 PMC: 11757300. DOI: 10.3389/fnins.2024.1530967.


Comparative effectiveness of various orbital decompression techniques in treating thyroid-associated ophthalmopathy: a systematic review and meta-analysis.

Guo W, Geng J, Li D BMC Ophthalmol. 2024; 24(1):526.

PMID: 39696149 PMC: 11653804. DOI: 10.1186/s12886-024-03749-3.


Novel immunoinflammatory blood markers in Graves' orbitopathy: insights into activity and severity.

Abounoori M, Pourazizi M, Kashkouli M, Akha O, Jafari R, Movahedirad M BMJ Open Ophthalmol. 2024; 9(1.

PMID: 39694546 PMC: 11683961. DOI: 10.1136/bmjophth-2024-001744.


Lacrimal gland enlargement in thyroid eye disease.

Rana K, Caltabiano C, Beecher M, Patel S, Slattery J, Chan W Int Ophthalmol. 2024; 44(1):431.

PMID: 39542958 DOI: 10.1007/s10792-024-03352-x.


References
1.
Ohtsuka K, Nakamura Y . Results of transmedial-canthal ethmoidal decompression for severe dysthyroid optic neuropathy. Jpn J Ophthalmol. 1999; 43(5):426-32. DOI: 10.1016/s0021-5155(99)00091-x. View

2.
Dickinson A, Perros P . Controversies in the clinical evaluation of active thyroid-associated orbitopathy: use of a detailed protocol with comparative photographs for objective assessment. Clin Endocrinol (Oxf). 2001; 55(3):283-303. DOI: 10.1046/j.1365-2265.2001.01349.x. View

3.
Giaconi J, Kazim M, Rho T, Pfaff C . CT scan evidence of dysthyroid optic neuropathy. Ophthalmic Plast Reconstr Surg. 2002; 18(3):177-82. DOI: 10.1097/00002341-200205000-00005. View

4.
Ambrosio G, Ferrara G, Vitale R, De Marco R . Visual evoked potentials in patients with Graves' ophthalmopathy complicated by ocular hypertension and suspect glaucoma or dysthyroid optic neuropathy. Doc Ophthalmol. 2003; 106(2):99-104. DOI: 10.1023/a:1022561530782. View

5.
Prummel M, Bakker A, Wiersinga W, Baldeschi L, Mourits M, Kendall-Taylor P . Multi-center study on the characteristics and treatment strategies of patients with Graves' orbitopathy: the first European Group on Graves' Orbitopathy experience. Eur J Endocrinol. 2003; 148(5):491-5. DOI: 10.1530/eje.0.1480491. View